Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
University of Utah
mi
from
Salt Lake City, UT
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
University of California at San Francisco
mi
from
San Francisco, CA
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
The University of Texas, Houston
mi
from
Houston, TX
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
The University of Texas, Houston
mi
from
Houston, TX
Click here to add this to my saved trials
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated:  8/25/2015
St. Joseph's Healthcare
mi
from
Hamilton,
Safety and Tolerability of Pirfenidone in Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
The LOTUSS Trial: An Open-Label, Randomized, Phase 2 Study of the Safety and Tolerability of Pirfenidone When Administered to Patients With Systemic Sclerosis−Related Interstitial Lung Disease (SSc-ILD) (LOTUSS)
Status: Enrolling
Updated: 8/25/2015
St. Joseph's Healthcare
mi
from
Hamilton,
Click here to add this to my saved trials
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated:  8/25/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated: 8/25/2015
VA Connecticut Health Care System
mi
from
West Haven, CT
Click here to add this to my saved trials
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated:  8/25/2015
VA Medical Center, Jamaica Plain Campus
mi
from
Boston, MA
Cognitive-behavior Therapy for MS-Related Chronic Pain
Cognitive-behavior Therapy for MS-Related Chronic Pain
Status: Enrolling
Updated: 8/25/2015
VA Medical Center, Jamaica Plain Campus
mi
from
Boston, MA
Click here to add this to my saved trials
Families Affected by Dementia: A Survey of Caregivers
Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia
Status: Enrolling
Updated:  8/26/2015
University of Miami
mi
from
Coral Gables, FL
Families Affected by Dementia: A Survey of Caregivers
Religion and Free Will Perceptions as Coping Mechanisms in Caregivers of Individuals With Dementia
Status: Enrolling
Updated: 8/26/2015
University of Miami
mi
from
Coral Gables, FL
Click here to add this to my saved trials
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia
Status: Enrolling
Updated:  8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Study for Treatment of Cancer in Children With Ataxia-telangiectasia
Pilot Study I for Treatment of Cancer in Children With Ataxia-Telangiectasia
Status: Enrolling
Updated: 8/26/2015
St. Jude Children's Research Hospital
mi
from
Memphis, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840041
mi
from
Phoenix, AZ
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840041
mi
from
Phoenix, AZ
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840209
mi
from
Tucson, AZ
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840209
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840033
mi
from
Loma Linda, CA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840033
mi
from
Loma Linda, CA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840034
mi
from
Modesto, CA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840034
mi
from
Modesto, CA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840090
mi
from
Fort Collins, CO
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840090
mi
from
Fort Collins, CO
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840011
mi
from
Fairfield, CT
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840011
mi
from
Fairfield, CT
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840013
mi
from
Maitland, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840013
mi
from
Maitland, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840230
mi
from
Ocala, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840230
mi
from
Ocala, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840022
mi
from
Ormond Beach, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840022
mi
from
Ormond Beach, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840025
mi
from
Sarasota, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840025
mi
from
Sarasota, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840082
mi
from
St. Petersburg, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840082
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840033
mi
from
Sunrise, FL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840033
mi
from
Sunrise, FL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840063
mi
from
Elk Grove Village, IL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840063
mi
from
Elk Grove Village, IL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840064
mi
from
Flossmoor, IL
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840064
mi
from
Flossmoor, IL
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840039
mi
from
Ft Wayne, IN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840039
mi
from
Ft Wayne, IN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840012
mi
from
Indianapolis, IN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840012
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840016
mi
from
Des Moines, IA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840016
mi
from
Des Moines, IA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840069
mi
from
Clinton Township, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840069
mi
from
Clinton Township, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840253
mi
from
Grand Rapids, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840253
mi
from
Grand Rapids, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840061
mi
from
Traverse City, MI
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840061
mi
from
Traverse City, MI
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840076
mi
from
Minneapolis, MN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840076
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840079
mi
from
Tupelo, MS
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840079
mi
from
Tupelo, MS
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840310
mi
from
St. Louis, MO
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840310
mi
from
St. Louis, MO
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840060
mi
from
Syracuse, NY
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840060
mi
from
Syracuse, NY
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840029
mi
from
Charlotte, NC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840029
mi
from
Charlotte, NC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840074
mi
from
Bismarck, ND
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840074
mi
from
Bismarck, ND
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840005
mi
from
Cincinnati, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840005
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840078
mi
from
Dayton, OH
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840078
mi
from
Dayton, OH
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840133
mi
from
Tulsa, OK
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840133
mi
from
Tulsa, OK
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840257
mi
from
Portland, OR
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840257
mi
from
Portland, OR
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840004
mi
from
Philadelphia, PA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840004
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840068
mi
from
Greenville, SC
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840068
mi
from
Greenville, SC
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840071
mi
from
Cordova, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840071
mi
from
Cordova, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840001
mi
from
Nashville, TN
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840001
mi
from
Nashville, TN
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840186
mi
from
San Antonio, TX
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840186
mi
from
San Antonio, TX
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840006
mi
from
Bennington, VT
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840006
mi
from
Bennington, VT
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840123
mi
from
Seattle, WA
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 840020
mi
from
Charleston, WV
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 840020
mi
from
Charleston, WV
Click here to add this to my saved trials
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated:  8/26/2015
Sanofi-Aventis Investigational Site Number 036005
mi
from
Bedford Park,
An Efficacy Study of Teriflunomide in Patients With Relapsing Multiple Sclerosis
A Multi-center Double-blind Parallel-group Placebo-controlled Study of the Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis
Status: Enrolling
Updated: 8/26/2015
Sanofi-Aventis Investigational Site Number 036005
mi
from
Bedford Park,
Click here to add this to my saved trials
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study
Status: Enrolling
Updated:  8/27/2015
Indiana University Medical Group
mi
from
Indianapolis, IN
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care
Perceptions Regarding Investigational Screening for Memory Problems in Primary Care: The PRISM-PC Study
Status: Enrolling
Updated: 8/27/2015
Indiana University Medical Group
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Indiana University
mi
from
Indianapolis, IN
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated:  8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
mi
from
New York, NY
A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of HPN-100 for Maintaining Remission in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy
Status: Enrolling
Updated: 8/27/2015
Columbia University Medical Center / Center for Liver Disease and Transplantation
mi
from
New York, NY
Click here to add this to my saved trials